News

Article

Pharmaceutical Technology

Pharmaceutical Technology-09-02-2005
Volume29
Issue 9

Analytical Method Equivalency: An Acceptable Analytical Practice

Participants in a 2003 PhRMA workshop present the industry’s current thinking on developing analytical method equivalency, including the importance of sample selection, acceptance criteria, data evaluation, and documentation.

External Link - article-178592.pdf

Articles in this issue
i1_t-179357-1408683578893.gif
Securing the Supply Chain With RFID
Applications of Poly(ethylene in Drug Delivery Systems: Part II
Analytical Method Equivalency: An Acceptable Analytical Practice
The Nation Needs a Comprehensive Pharmaceutical Engineering Education and Research System
September 2005
Pilots and Partnerships Move RFID Forward
Reshaping CMC Development Services
Wash. Rinse. Repeat
i2-179358-1408683576722.gif
Artificial Distinctions: Protein A Mimetic Ligands for Bioprocess Separations
i1-179351-1408683585762.jpg
Outsourcing Atrophy: A Cautionary Tale
In the Spotlight-September 2005
FDA Faces Multiple Challenges

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Related Content
automatic stainless steel pharmaceutical fermenter | Image Credit: ©gen_A - stock.adobe.com
July 31st 2025

In-line UV Spectrometry Monitoring in Cleaning Validation

John Schallom Brian Bosso Paul Lopolito Katie Frey Amy Thanavaro
The authors performed interference and enhancement testing using a formulated alkaline and acid cleaner, as well as common biopharmaceutical process residues.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
July 31st 2025

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Magnifier with pills on blue background | Image Credit: © Pixel-Shot - stock.adobe.com
July 31st 2025

Overcoming PK/PD Modeling Challenges

Cynthia A. Challener
Artificial intelligence and machine learning can help identify complex patterns.
A magnifying glass examining a vintage vaccine vial surrounded by four minimalistic chart icons, symbolizing healthcare, medicine, and analytics in the context of global health monitoring. | Image source: ©huiying - stock.adobe.com
July 31st 2025

ICH Q6B for Analytics

Richard Easton Christopher Ziegenfuss
ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.
Image Credit: © Alessandro Grandini - stock.adobe.com
July 31st 2025

Understanding the Variability in Bioburden Test Results in Biomanufacturing

Naveenganesh Muralidharan
This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Unidentified microbiologist is place the petri dish and tubes into incubator to incubate the culture of bacteria or fungi growth in appropriate condition, concept of microbial laboratory. | Image Credit: © Sukjai Photo – © Sukjai Photo – Stock.Adobe.com
July 31st 2025

Evolving Cleanroom Procedures and Sterility Challenges

Feliza Mirasol
The shift toward personalized medicines poses new challenges in cleanroom protocols.